Dedicare AB (publ) (FRA:CL6)

Intra-Cellular Therapies Statistics

Total Valuation

Dedicare AB has a market cap or net worth of EUR 39.18 million. The enterprise value is 32.68 million.

Market Cap	39.18M
Enterprise Value	32.68M

Important Dates

The last earnings date was Friday, July 11, 2025.

Earnings Date	Jul 11, 2025
Ex-Dividend Date	Apr 29, 2025

Share Statistics

Current Share Class	7.55M
Shares Outstanding	n/a
Shares Change (YoY)	-0.54%
Shares Change (QoQ)	-0.22%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.57M

Valuation Ratios

The trailing PE ratio is 11.74.

PE Ratio	11.74
Forward PE	n/a
PS Ratio	0.28
PB Ratio	1.55
P/TBV Ratio	3.44
P/FCF Ratio	6.62
P/OCF Ratio	6.77
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.39, with an EV/FCF ratio of 5.52.

EV / Earnings	9.79
EV / Sales	0.24
EV / EBITDA	7.39
EV / EBIT	14.78
EV / FCF	5.52

Financial Position

The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.08.

Current Ratio	1.45
Quick Ratio	1.45
Debt / Equity	0.08
Debt / EBITDA	0.45
Debt / FCF	0.34
Interest Coverage	4.87

Financial Efficiency

Return on equity (ROE) is 13.28% and return on invested capital (ROIC) is 5.19%.

Return on Equity (ROE)	13.28%
Return on Assets (ROA)	2.52%
Return on Invested Capital (ROIC)	5.19%
Return on Capital Employed (ROCE)	7.74%
Revenue Per Employee	149,983
Profits Per Employee	3,596
Employee Count	1,061
Asset Turnover	2.53
Inventory Turnover	n/a

Taxes

In the past 12 months, Dedicare AB has paid 848,781 in taxes.

Income Tax	848,781
Effective Tax Rate	20.28%

Stock Price Statistics

The stock price has decreased by -34.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-34.27%
50-Day Moving Average	3.99
200-Day Moving Average	4.54
Relative Strength Index (RSI)	52.62
Average Volume (20 Days)	1,215

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dedicare AB had revenue of EUR 139.18 million and earned 3.34 million in profits. Earnings per share was 0.35.

Revenue	139.18M
Gross Profit	21.25M
Operating Income	2.22M
Pretax Income	4.19M
Net Income	3.34M
EBITDA	3.13M
EBIT	2.22M
Earnings Per Share (EPS)	0.35

Balance Sheet

The company has 8.51 million in cash and 2.00 million in debt, giving a net cash position of 6.51 million.

Cash & Cash Equivalents	8.51M
Total Debt	2.00M
Net Cash	6.51M
Net Cash Per Share	n/a
Equity (Book Value)	25.30M
Book Value Per Share	2.65
Working Capital	9.93M

Cash Flow

In the last 12 months, operating cash flow was 5.78 million and capital expenditures 135,121, giving a free cash flow of 5.92 million.

Operating Cash Flow	5.78M
Capital Expenditures	135,121
Free Cash Flow	5.92M
FCF Per Share	n/a

Margins

Gross margin is 15.27%, with operating and profit margins of 1.59% and 2.40%.

Gross Margin	15.27%
Operating Margin	1.59%
Pretax Margin	3.01%
Profit Margin	2.40%
EBITDA Margin	2.25%
EBIT Margin	1.59%
FCF Margin	4.25%

Dividends & Yields

This stock pays an annual dividend of 0.23, which amounts to a dividend yield of 5.76%.

Dividend Per Share	0.23
Dividend Yield	5.76%
Dividend Growth (YoY)	-58.91%
Years of Dividend Growth	2
Payout Ratio	64.01%
Buyback Yield	0.54%
Shareholder Yield	6.30%
Earnings Yield	8.52%
FCF Yield	15.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5